Armata Pharmaceuticals, Inc.ARMPNYSE
Loading
Cost of Revenue Over TimeContracting
Percentile Rank64
3Y CAGR-65.2%
5Y CAGR-36.6%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
-65.2%/yr
vs +125.6%/yr prior
5Y CAGR
-36.6%/yr
Recent deceleration
Acceleration
-190.8pp
Decelerating
Percentile
P64
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $1.48M | -95.7% |
| 2024 | $34.43M | +3441.8% |
| 2023 | $972000.00 | -97.2% |
| 2022 | $35.02M | +75.0% |
| 2021 | $20.02M | +38.6% |
| 2020 | $14.44M | +969.1% |
| 2019 | $1.35M | 0.0% |
| 2018 | $1.35M | +261.2% |
| 2017 | $374000.00 | +1.4% |
| 2016 | $369000.00 | - |